News and Trends 28 Sep 2018 Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M …cells called regulatory T cells. These cells hold back the immune system from attacking tumors, thus the antibody helps the patient’s immune system to fight the cancer. The antibody has… September 28, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 26 Mar 2024 Large molecule manufacturing: addressing challenges with strategies for success …the characteristics of the molecule. This panel of offerings covers a broad range of protein modalities that include antibody-based products, such as bispecific antibodies, Fc-Fusion proteins, and antibody fragments, and… March 26, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 16 Feb 2023 Maxion Therapeutics raises $16M to target GPCRs …co-founded CAT (acquired by AstraZeneca for £700 million) and IONTAS (acquired by FairJourney Biologics). At CAT, McCafferty co-invented antibody phage display, the technology used to discover the world’s best-selling drug,… February 16, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Weekly Roundup 24 Nov 2023 Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA …an antibody that was discovered based on WuXi Bio’s integrated technology platforms, so that Myricx can develop an ADC using the antibody, to target solid tumors, through its NMT-1 platform…. November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …agonist for right heart failure and potentially other cardiometabolic diseases. COR-2007: An AVP-neutralizing monoclonal antibody aimed at treating acute heart failure with hyponatremia. DiogenX Founded: 2020 Headquarters: Marseille, France Focus:… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Feb 2024 Future of cancer treatment: what will therapy look like in 2034? …the clinic. Maher expects antibody-based therapeutics to continue to yield new drugs like immunomodulatory agents and antibody drug conjugates “that deliver ever more powerful poisons in a selective manner to… February 5, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jun 2025 Life sciences in Wales: biotechs in the scene in 2025 …Antiverse Founded in 2017 Technology: Antibody discovery and development Latest funding: $4.6 million investment AI has accelerated innovation in the world of biotech. Over the years, it has bolstered antibody… June 30, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 Nov 2016 Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction …therapeutic antibody’s development due to the similarity of the cells to human cells (e.g. folding, glycosylation etc). For example, CHO-K1-based cell lines, derived from the ovarian cells of the Chinese… November 19, 2016 - 4 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Oct 2025 Seven of the top biotech companies to know about in South San Francisco …a phase 2 trial. Calico also recently entered into an agreement with Chinese biotech Mabwell Bioscience for the rights to IL-11 directed therapeutics, including 9MW3811, a phase 1 monoclonal antibody… October 21, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jun 2022 ImCheck raises €96M in funding round French biotech company ImCheck has announced funding of €96 million ($101.5 million) to investigate antibody drugs with the ability to activate the powerful immune cells called gamma delta T (gdT)…. June 17, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for …target cancer cells. The B-cell cancer vaccines are meant to induce antibody production against proteins like HER2 and PD-1, which can in turn bind to the vaccine’s antigens to stimulate… March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 14 Nov 2022 In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus …long-acting antibody designed for all infants for protection against RSV disease from birth through their first RSV season with a single dose, is being developed jointly by AstraZeneca and Sanofi… November 14, 2022 - 9 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email